INTRODUCTION
Expression cloning has a track record in discovering novel genes based on their function. Typically, identi®cation of a single gene consists of several screening rounds of a cDNA expression library for a speci®c trait, such as proliferation, DNA binding or cell surface expression. Successful expression cloning of proliferation-inducing genes requires ef®cient transfer of cDNA pools into mitotically inactive primary cells. We suggest cDNA libraries engineered into a lentiviral expression setting to be the preferred con®guration for functional expression cloning. Retroviruses are lipid-enveloped particles comprising a homodimer of linear, positive-sense, singlestranded RNA genomes that replicate via a DNA intermediate (1) . Oncoretroviral and lentiviral vectors exhibit a large cloning capacity and enable long-term expression of desired transgenes following integration into the target chromosomes. Pseudotyping of transgenic retroviral particles extends their tropism and increases their transduction ef®ciency. The multitropism of VSV-G-pseudotyped lentiviruses facilitates screening of a single lentiviral cDNA expression library in a variety of different cells or tissues. Although very similar in their genetic set-up, oncoretroviruses only infect dividing cells whereas lentiviruses can infect and replicate in non-mitotic cells (2, 3) . Typically, oncoretroviral/lentiviral transduction rates are a function of the multiplicity of infection (m.o.i.). Depending on the m.o.i., the fraction of transduced cells can vary from 1 to 95%. By increasing the m.o.i., a single cell can be transduced by more than one cDNA-encoding viral particle, resulting in coexpression of a gene pool. This retroviral characteristic enables elucidation of combinatorial effects of several genes coexpressed in a single target cell.
Most of today's available lentiviral expression vectors have been designed by eliminating pathogenic transcription units from the viral genome while retaining cis-acting elements essential for packaging and reverse transcription. Transgenic non-pathogenic and replication-incompetent lentiviral particles are produced following cotransfection of three separate vectors into a helper cell line: (i) the transfer construct containing viral cis-acting elements as well as the desired transgene, (ii) the packaging construct encoding structural and (iii) envelope proteins (4) . In order to increase biosafety and reduce promoter interference, self-inactivating (SIN) lentivectors have become the standard for transduction of proliferation-inert cells. The SIN lentiviruses harbor a deletion in their 3¢ LTR that results in inactivation of 5¢ LTRassociated promoter/enhancer activities following reverse transcription and integration into the target chromosome (5) . Recently, we have engineered a series of self-inactivating lentiviral vectors which contain (i) unmatched polylinkers with up to 29 unique sites for restriction endonucleases, (ii) strong promoters derived from human cytomegalovirus immediate-early or the human elongation factor 1a promoters and/or (iii) tricistronic expression cassettes for coordinated expression of up to three transgenes (6) .
Cell proliferation failures are associated with a number of human pathologies including multiple sclerosis, osteoarthritis as well as Parkinson's and Alzheimer's disease. Cloning of novel proliferation-inducing genes may have therapeutic implications for tissue regeneration as well as the treatment of tissue-degenerative disorders. We have developed an expression cloning strategy for the discovery of growthpromoting determinants using a combination of retroviral and lentiviral transduction technologies. Screening of a human brain cDNA library expressed in human umbilical vein endothelial cells (HUVEC) resulted in the identi®cation of pi1, a novel proliferation-inducing cDNA.
MATERIALS AND METHODS

Cell culture
HEK293-T (6), Swiss3T3 ®broblasts (provided by Urs Ziegler) and HeLa (ATCC CCL-2) cells were cultured in Dulbecco's modi®ed Eagle's medium (Invitrogen, Carlsbad, CA) supplemented with 10% heat-inactivated fetal calf serum (FCS) (PAA, Vienna, Austria; lot no. A01129-242), 100 U penicillin and 100 mg/ml streptomycin (Sigma Chemicals, St Louis, MO) in a humidi®ed atmosphere containing 5% CO 2 at 37°C. HUVECs were dissected and cultured as previously described (7) . HUVECs of the ®rst passages were used. Cells were transfected using either calcium phosphate-based protocols or FuGENE6 transfection reagent (Roche Molecular Biochemicals, Rotkreuz, Switzerland).
FACS analysis
Cells were dissociated from the culture dish by trypsinization, resuspended in PBS containing 1% FCS and the¯uorescence was quanti®ed using a Beckman Counter EPICS XL¯ow cytometer (Beckman Coulter Intl. SA, Nyon, Switzerland).
Genomic DNA isolation
Cells (5 Q 10 5 ) were washed, collected in PBS and pelleted. The cells were lysed in lysis buffer (10 mM Tris±Cl; 50 mM KCl; 1.5 mM MgCl2; 0.45% Tween 20; 0.5% Triton X-100) and proteinase K (Qiagen, Basel, Switzerland) was added to the lysate for 45 min at 50°C. The DNA was puri®ed by phenol/ chloroform extraction followed by ethanol precipitation.
Cell proliferation assay
Cell proliferation assay using Brd-uridine incorporation was performed using the Cell Proliferation ELISA kit (Roche Molecular Biochemicals, Rotkreuz, Switzerland) according to the manufacturer's instruction. In brief, cells were seeded into 96-well plates at different concentrations, allowed to adhere for 24 h and transfected with either the pPI1-His or isogenic control vectors. Proliferation was quanti®ed 36 h post-transfection.
Western blotting
Bacterial lysates were resolved on SDS±polyacrylamide gels and transferred to Immobilon-P membranes (Millipore Corporation, Bedford, MA) using standard procedures. The membrane was blocked with 4% (w/v) instant non-fat milk powder (Coop, Switzerland) and incubated for 2 h with antiHis antibodies (Novagen, Madison, WI) diluted in PBS containing 4% non-fat milk powder. His-tagged proteins were visualized following incubation with goat anti-mouse horseradish peroxidase-coupled antibody and ECL detection reagents (Amersham Biosciences, UK).
Construction of plasmids and the cDNA library
The lentiviral expression vector pDC32 was constructed by cloning the P hCMV -encoding BamHI/KpnI fragment, PCRampli®ed from pcDNA3.1/V5-His-TOPO (Invitrogen, Carlsbad, CA), BamHI/KpnI into pMF388 (6) . The following primers were used for ampli®cation of P hCMV : ODC1: 5¢-GGGGTACCGCCAGATATACGCGTTGACA-3¢ and ODC2 5¢-CGGGATCCACGTGAGCCAGTAAGCAGTGGGTTC-3¢ (annealing sequences are underlined, extensions containing KpnI and BamHI/PmlI restriction sites are shown in bold). The double-stranded (ds) cDNA library was constructed from human adult brain total RNA (Invitrogen, Carlsbad, CA) using the NotI-containing oligo-d(T) for priming and the Copy Kit cDNA synthesis system (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. The ds cDNA was blunted using DNA polymerase I followed by NotI digestion and gel puri®cation. The NotI-digested ds cDNA was ligated into the NotI±PmlI sites of pDC32 resulting in the lentivectorbased cDNA library. The lentivector-encoded cDNA library was converted into replication-incompetent lentiviral particles following recently described protocols (6) . The titer of the library was determined using the p24 ELISA assay (NEK-050, Perkin Elmer, Boston, MA).
Transduced cDNA inserts of interest were PCR-ampli®ed from the genomic DNA using primers ODC3: 5¢-GAGACA-GAGACAGATCCATTCG-3¢ (annealing to nucleotides 2372±2393 of pMF388) and ODC4: 5¢-CGTGTACGGTGG-GAGGTCTA-3¢ [annealing to nucleotides 786±805 of pcDNA3.1/V5HisTOPO (corresponding to P hCMV )] and the following PCR program: annealing temperature of the ®rst two cycles was 64°C which was subsequently decreased by 2°C per two cycles until a ®nal annealing temperature of 54°C was reached. At 54°C an additional 20 cycles were run. The products of the ®rst ampli®cation round were diluted 1:20 in H 2 O and used as template for the second PCR employing identical primers and reaction conditions. The ®nal PCR product was subcloned into pcDNA3.1/V5-His-TOPO (Invitrogen, Carlsbad, CA) to result in pPCR102-2. The novel cDNA sequence contained within pPCR102-2 has been deposited in the GenBank database (accession no. AY255855). All PCR reactions were conducted using DyNAzyme.EXT polymerase (Finnzymes, Oulu, Finland). pND-A2 and pND-A8 represent nested deletions of pPCR102-2 which were performed by restricting pPCR102-2 with KpnI and BamHI followed by Exonuclease III (NEB, Beverly, MA) mediated digestion at 37°C for 1, 2 and 3 min, respectively. The Exonuclease III reaction was stopped in liquid nitrogen and the enzyme was subsequently heat inactivated. The digestion products were blunted using Mung Bean Nuclease (BD Biosciences, Palo Alto, CA) and recircularized followed by bacterial transformation and plasmid DNA puri®cation. The pPI1-His construct was obtained by PCR-mediated ampli®cation of pi1 from pPCR102-2 using primers OD5: 5¢-CGGGATCCATGGATCTGTCTCAGTCTCAGTCTC-3¢ and OD6: 5¢-CCCGATATCAGACAGAGACAATCCATT-CGAACAGA-3¢, (annealing sequences are underlined and extensions containing BamHI and EcoRV restriction sites are shown in bold) followed by cloning of the BamHI/EcoRVdigested pi1-encoding PCR product into BamHI/EcoRVrestricted pEF6/V5-His-TOPO (Invitrogen, Carlsbad, CA), in-frame with histidine tag and stop codon. The prokaryotic pi1 expression vector pDC106 was constructed by PCRmediated ampli®cation of pi1 from pPI1-His using OD7: 5¢-CACCATGGATCTGTCTCAGTCTCAGTCTC-3¢ and OD8: 5¢-AACTAGAAGGCACAGTCGAGGCTG-3¢
(annealing sequences are underlined). OD8 corresponds to nucleotides 1108±1131 of pcDNA3.1/V5-His-TOPO (Invitrogen, Carlsbad, CA) and OD7 to nucleotides 1±25 of the pi1. The PCR product was puri®ed and cloned into the prokaryotic expression vector pET101-D (Invitrogen, Carlsbad, CA). The oncoretroviral vector pLEGFP-N1 encoding the enhanced green¯uorescent protein (GFP) was obtained from BD Biosciences (Palo Alto, CA).
Lentivirus and oncoretrovirus production
Lentiviruses were produced as described previously (6) . In brief, equal amounts of the helper construct pCD/NL-BH (8), the envelope construct pLTR-G (9) and the transfer construct containing the desired transgene were transiently transfected into HEK293-T cells and the virus-enriched cell supernatant was collected 3 days later, ®ltered and frozen in aliquots. pLEGFP-N1-derived GFP-encoding oncoretrovirus was produced using the Retro-X Expression System (BD Biosciences, Palo Alto, CA) according to the manufacturer's protocols.
RESULTS
Lentiviral expression cloning/screening for the discovery of proliferation-inducing genes
In order to identify novel growth-promoting genes we have developed a cDNA library screening system based on the sequential combination of two expression technologies: transduction of proliferation-inert cells or tissues using a lentiviral cDNA expression library, followed by selection of proliferation-competent cells targeted by a GFP-encoding oncoretrovirus. Figure 1A Since RNA synthesis represents a key step in the retroviral life cycle, the desired transgene expression unit integrated into a retroviral transduction con®guration should be devoid of any 5¢±3¢ poly(A) signals. Figure 1B shows a schematic representation of the lentivirus-derived transfer vector pDC32 engineered to support expression of a poly(A) signal-containing cDNA insert. The pMF388 (6) derivative pDC32 is sizeoptimized and contains a strong constitutive promoter derived from the human cytomegalovirus immediate early promoter (P hCMV ) in 3¢±5¢ orientation. P hCMV is¯anked by cis-acting viral elements including the extended packaging signal (Y + ) as well as 5¢ and 3¢ long terminal repeats (LTR). Since poly(A) signals are known to function in an orientation-dependent 
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Nucleic Acids Research, 2003, Vol. 31, No. 18 e113 manner they are not expected to interfere with reverse transcription when placed in antisense orientation. In addition, due to a deletion in the 3¢ LTR, pCD32-derived lentivectors are self-inactivated, preventing any 5¢ LTR-based interference with expression of the cDNA or endogenous genes adjacent to the chromosomal insert. In order to validate the pDC32-based lentiviral expression con®guration, a GFP-encoding expression cassette (P hCMV -gfp-pA) was inserted into pDC32 followed by production and transduction of transgenic lentiviral particles into CHO-K1 cells. Based on¯uorescence microscopy, close to 50% of the transduced cells scored positive for GFP expression (data not shown), thus con®rming that 3¢±5¢ orientation of the expression cassette is compatible with lentivirus production and enables ef®cient transgene expression. Next, a ds cDNA library synthesized from adult human brain total RNA was cloned into pDC32. The oligod(T) used for priming of ®rst strand synthesis contained a NotI restriction endonuclease site to enable directional cloning into pDC32. Over 4 Q 10 5 independent clones were obtained, pooled and their plasmid DNA isolated. The puri®ed lentivector DNA was used to produce a library of lentiviral particles containing P hCMV -driven adult human brain cDNAs. The virus titer determined using a p24 immunoassay was 127.4 T 15.1 ng/ml correlating with 2±3 Q 10 7 infectious particles per ml.
Isolation of proliferation-promoting determinants
In order to identify novel proliferation-inducing genes, mitotically quiescent HUVECs were transduced with a lentivirus library transgenic for adult human brain cDNAs at m.o.i. up to 10. Three days post-transduction, the cells were retransduced using a GFP-encoding oncoretrovirus pLEGFP-N1, which exclusively targets HUVECs that underwent cellcycle re-entry. pLEGFP-N1-transduced cell populations were gated for GFP expression and single cell-sorted by FACS 48 h post pLEGFP-N1 transduction. Single GFP-expressing cells were seeded onto 96-well cell culture plates and allowed to expand. Out of 12 GFP-expressing cell clones, three survived triple passage and expansion indicating that they were transduced by lentiviruses encoding proliferation-inducing genes. Genomic DNA was extracted from the transgenic proliferation-competent HUVEC cell derivatives and a chromosomally integrated library cDNA could be PCRampli®ed from a single clone using primers ODC3 and ODC4 (Fig. 1B) . The DNA fragment was cloned into the mammalian expression vector pcDNA3.1 to yield pPCR102-2. pPCR102-2 was found to contain a unique novel sequence spanning about 300 nucleotides¯anked by the expected lentivector stretches (Fig. 2) . The deduced amino acid sequence of the cDNA insert of pPCR102-2 revealed an open reading frame (ORF) of 297 bp coding for a putative protein of 10 kDa. Sequence similarity searches in the human genome database revealed an overall 39% homology of the deduced polypeptide to the hypothetical human protein XP_086050 on chromosome 19 (19p13.11).
Characterization of a novel proliferation-inducing cDNA
In order to demonstrate whether expression of the pPCR102-2-encoded polypeptide can induce proliferation, we quanti®ed GFP-mediated¯uorescence of pPCR102-2-transfected HUVECs following transduction with pLEGFP-N1. Since pLEGFP-N1 can integrate only into chromosomes of proliferating cells, GFP¯uorescence levels correlate with the number of proliferation-competent cells in transgenic HUVEC populations. Figure 3A shows FACS-assessed GFP-mediated uorescence levels of HUVECs, transfected either with pPCR102-2 or an isogenic control vector (pcDNA3.1/V5-His-TOPO), 48 h post-transduction with pLEGFP-N1. We observed that pPCR102-2-transfected HUVEC populations showed up to 15-fold higher green¯uorescence levels compared to control cells. In order to exclude that proliferation was induced by interference of a non-coding RNA transcribed from the viral DNA encoded on pPCR102-2 clone, we have created several pPCR102-2 derivatives containing truncated/modi®ed cDNA inserts. In pND-A8 viral sequences 5¢ of the putative ORF were deleted (Fig. 2) . The FACS analysis of HUVECs, transfected with either pND-A8 or isogenic control DNA and subsequently transduced with pLEGFP-N1 revealed nearly 6-fold higher proliferation rate in pND-A8-transfected cells compared to control cell populations (Fig. 3B) . Furthermore, pND-A2 lacking viral sequences as well as the putative ATG start codon of the ORF shows no proliferation-modulating effects on HUVECs (Fig. 3C) . Finally, we have tagged the 297 bp-long ORF by fusing it N-terminally to a His-tag and a TAA STOP codon (Fig. 2,  pPI1-His) . FACS analysis of the pLEGFP-N1-transduced HUVECs revealed that cells pretransfected with pPI1-His showed a 4-fold higher GFP-mediated¯uorescence compared to HUVEC populations transfected with the control vector (Fig. 3D) . The overall reduction in proliferation-inducing potential associated with elimination of viral sequences may result from transcription-and/or translation-enhancing activites contained in cis-acting viral sequences. All results are consistent with the fact that the unique cDNA fragment Figure 2 . Structure of pPCR102-2 and its derivatives encoding different modules of the proliferation-inducing cDNA. In pPCR102-2, the novel proliferation-inducing cDNA is¯anked by viral sequences and contains an ORF. In order to narrow down the proliferation-inducing ORF, we constructed pND-A8 containing 5¢ deletions of viral sequences, pND-A2 harboring a deletion of the ATG start codon of ORF and pPI1-His encoding full-length PI1 ORF fused in-frame to a histidine tag. pPCR102-2 derivatives were produced by deleting sequences either upstream or including the putative start ATG of the ORF. All constructs were cloned under control of P hCMV . contained on pPCR102-2 encodes a polypeptide able to induce proliferation in HUVECs, which we call PI1 (proliferation inducer 1). Indeed, conditional IPTG-induced expression of His-tagged piI in Escherichia coli resulted in production of a single 15 kDa (15 kDa, PI1 plus His-tag; 10 kDa PI1 only) protein following 4 h of IPTG induction (Fig. 4) .
PI1-induced cell proliferation
In order to quantify the direct impact of the PI1 on DNA synthesis of mammalian cells we have performed Brd-uridine incorporation-based cell proliferation assays. HUVECs transfected with the pPI1-His showed enhanced Brd-uridine incorporation in comparison with mock-transfected cells which indicates increased proliferation (Fig. 5A) . Increases in DNA synthesis ranged from 20 to 80%, depending on the cell density on the day of transfection. Similar results were obtained in Swiss3T3 ®broblasts (Fig. 5B) . When PI1 was expressed in con¯uent cells it was unable to increase proliferation indicating that PI1 is not an oncogene ( Fig. 5A  and B) .
DISCUSSION
Gene-function analysis is one of the key scienti®c activities in the post-genomic era. Many genes are only expressed in small quantities, at speci®c times during development or in a subset of tissues. Based on their (i) high transduction ef®ciency, (ii) stable integration into the host chromosome, (iii) broad tissue tropism following pseudotyping and (iv) their capacity to target mitotically inactive cells (10±14), we designed a novel lentiviral expression cloning strategy for the detection of proliferation-inducing determinants. As exempli®ed by cloning of PI1 cDNA the discovery of novel proliferation-inducing determinants using lentiviral expression cloning consists of three consecutive steps. (i) Transduction of a lentiviral cDNA produced from tissues containing proliferation-competent cells into proliferation-inert target cells. (ii) Targeting, isolation and expansion of cDNA expressing proliferating cell clones using a reporter gene-encoding oncoretrovirus which exclusively transduces mitotically active cells. (iii) Cloning of chromosomal cDNA inserts by PCR-mediated ampli®cation from¯anking viral sequences.
Our initial decision to screen for proliferation-inducing genes using a human brain cDNA expression library in order to validate lentiviral expression cloning was based on recent (17, 18 ). An inherent challenge for cloning of proliferation-inducing cDNAs using retroviral systems is their capacity to induce uncontrolled transgene-independent growth as a result of random integration into the target chromosome. In order to minimize unspeci®c growth-induction it is essential that the target cells are proliferation-inert which is the case for most differentiated primary cells. Our results using HUVECs as a proliferation-inert reporter cell line exempli®es the possibility of isolating growth-promoting genes in a single screening step. PI1 is a 10 kDa protein that induces proliferation in sparse HUVEC and Swiss3T3 ®broblast cultures while it shows no growth-promoting effect on con¯uent cells. The ®nding that contact inhibition seems to be dominant over PI1 action suggests that this protein lacks transformation potential. PI1 might therefore be considered for expansion of primary cells in tissue engineering scenarios that require timely growth induction without becoming neoplastic.
The use of lentiviral cDNA expression libraries is not limited to screening for growth-inducing genes. The same library could be used to discover genes involved in any cell phenotype-modulating process as long as there are tools to detect desired cell phenotypes. With the cloning of PI1, lentiviral expression cloning has become a molecular reality and the newest chapter in the success story of expression technology. Taking advantage of pantropic transduction capacity and the ability to deliver transgenes into nonproliferating primary cells, lentiviral expression cloning is expected to enable a new dimension in gene discovery and gene-function analysis in the post genomic era.
